Clinical Trials Browser

Phase EARLY_PHASE1 × Laryngeal Diseases × Clear all

NCT06819228 2026-05-08

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

Phase EARLY_PHASE1 Recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Mouth Neoplasms, Tongue Neoplasms

NCT03109873 2025-04-30

Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer

Phase EARLY_PHASE1 Completed

9 enrolled 6 charts

Lymphoid Interstitial Pneumonia, Laryngeal Diseases

NCT03162731 2025-04-29

Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer

Phase EARLY_PHASE1 Completed

Lymphoid Interstitial Pneumonia, Laryngeal Diseases

NCT00743353 2009-02-02

K5

Phase EARLY_PHASE1 Completed

BreastCNSDermatologicHead & NeckSarcomaThoracic

Astrocytoma, Breast Neoplasms, Glioblastoma, Laryngeal Diseases, Lung Neoplasms, Melanoma, Oligodendroglioma, Sarcoma